RxDoctor Payments Data

Donna Grand, CNM

Advanced Practice Midwife · Huntington Station, NYNPI 1861557274

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Mayne Pharma Commercial LLC at 25.8% of the total. Reporting peaked in 2023 at $1,028 and has fallen 70.7% since, to $302 in 2024. Among advanced practice midwife clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,530in general payments, 2019–2025

Across 104 payments — averaging $24.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mayne Pharma Commercial LLC$653
  • AbbVie$449
  • Daiichi Sankyo Inc.$217
  • Organon$149
  • Scynexis, Inc.$139
  • Myovant Sciences Inc.$128
  • plus $796 from 14 others

What the payments were for

  • Food & beverage$2,530100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,530 in reported general payments places this provider in the 95th percentile of 364 advanced practice midwife providers in New York.

See all advanced practice midwife providers in New York

Medicare billing

Part B allowed, 2024
$5,724
Medicare patients
59
Services billed
124

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Medroxyprogesterone Acetate12$692
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip11$293

Paid to pharmacies, not to this prescriber.

Other advanced practice midwife in Huntington Station

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →